Medterra’s latest partnership is aimed at growing the company's CBD consumer base internationally. The brand is working with Montevideo, Uruguay-based Megalabs to bring its CBD products to the Mexican, Argentinian and Brazilian markets. 

Megalabs’ Latin American distribution network will be used to advance Medterra’s global expansion, the companies said. 

"Over this last year we have been working with the Megalabs team to plan this entrance into the Latin America markets," said Jay Hartenbach, CEO of Medterra. "Our success to date has always been centered around strategic partners and we believe Megalabs is exactly the team we need to be successful in these countries. To bring high-quality CBD to those that need it has been our singular goal since Medterra's inception and this marks a significant step in reaching that goal."

The companies’ agreement grants Megalabs the exclusive rights to commercialize Medterra products in Brazil, Mexico and Argentina. 

"This is going to be good for everyone, especially for the people that will have more access to quality CBD,” Hartenbach said. “We are always hopeful to be able to utilize our passion for this plant and its potential for the good of all who may need it.”